CD4 and Parkinson disease: While the MPTP model compellingly demonstrates that peripheral CD4 + T cells are necessary and sufficient to drive neurodegeneration, our study confirms that a parallel phenomenon—characterized by CD4 gene dysregulation and linked to specific non-coding RNA networks—is indeed present in the peripheral immune system of human PD patients.